| Dr Cory Doran Spencer, MD | |
|
2280 Harrison Ave, Suite B, Eureka, CA 95501-3200 | |
| (707) 443-9371 | |
| Not Available |
| Full Name | Dr Cory Doran Spencer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 2280 Harrison Ave, Eureka, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578669149 | NPI | - | NPPES |
| 00G714560 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | G71456 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cory Doran Spencer, MD 2280 Harrison Ave, Suite B, Eureka, CA 95501-3200 Ph: (707) 443-9371 | Dr Cory Doran Spencer, MD 2280 Harrison Ave, Suite B, Eureka, CA 95501-3200 Ph: (707) 443-9371 |
News Archive
In a collaboration between Kaiser Health News and The Washington Post, Elizabeth Olson writes about how emerging technology is helping older people stay in their homes and can, in some instances, offer mechanisms to improve patient outcomes and reduce health care costs.
As genetic sequences of SARS-CoV-2, the cause of the novel pneumonia (COVID-19), are similar to those of the 2003 SARS virus, SARS-CoV, knowledge and data of SARS-CoV may be useful for finding ways to combat COVID-19.
The study found that almost three fourths of those 80 years and older have hypertension - blood pressure greater than 140 systolic over greater than 90 diastolic. Fewer than 10 percent have "normal" blood pressure levels - less than 120 systolic over less than 80 diastolic.
ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that the company's clinical data from ICT-107 will be featured in two oral sessions at the World Stem Cell Summit, which is being held October 4-6 in Detroit, MI.
A group of researchers at Osaka University elucidated how a gene named Ly6/Plaur domain containing 8 (Lypd8) inhibits bacterial invasion of colonic epithelia, regulating intestinal inflammation. This achievement may lead to the development of drugs for ulcerative colitis.
› Verified 3 days ago
Celeste Maxine Sayles-croy, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2200 Tydd St, Eureka, CA 95501 Phone: 707-441-1624 | |
Dr. Join Y. Luh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-269-4229 Fax: 707-269-3849 | |
Dr. Shyamal Kumar Maitra, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2280 Harrison Ave Ste B, C/o Eurka Internal Medicine, Eureka, CA 95501 Phone: 707-443-9371 Fax: 707-443-2620 | |
Dr. Lisa Michelle Crabtree, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-269-4253 | |
John Angel Sotelo, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2700 Dolbeer St, St. Joseph Hospital - Eureka, Eureka, CA 95501 Phone: 707-445-8121 | |
Dr. Gloria Beth Abels, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2280 Harrison Ave, Suite B, Eureka, CA 95501 Phone: 707-443-9371 | |
Dr. Kusum G Stokes, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3200 Walford Ave, Eureka, CA 95503 Phone: 707-443-4869 Fax: 707-442-5095 |